Breakthroughs

Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS.PP-UNP-GBR-10718 / November 2024

Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community.PP-UNP-GBR-9699 / August 2024

Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK, to explore the impact that migraine has on individuals and wider society.PP-UNP-GBR-8670 / April 2024

Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-7436 / November 2023

Dr Ellie Cannon is joined by Dr Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK (at time of recording), to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.PP-UNP-GBR-12704 / July 2025

Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society. PP-UNP-GBR-11741 / March 2025

Join Dr Ellie Cannon as she talks to Susan Rienow, Country President at Pfizer UK (at time of recording) and Dr Richard Torbett, CEO of the Association of the British Pharmaceutical Industry, about the lessons learnt from the COVID-19 pandemic and how this could be applied to address other major healthcare challenges.PP-UNP-GBR-10858 / November 2024